Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Insurance Subcommittee Chair Encourages Member Engagement

Carina Stanton  |  January 20, 2022

The ACR advocates for rheumatology on many levels, and Rebecca Shepherd, MD, MBA, FACR, FACP, new chair of the Insurance Subcommittee (ISC) of the ACR’s Committee on Rheumatologic Care (CORC), has a special interest in the advocacy between ACR member practices and both private and government payers.

Dr. Shepherd

“We are practicing in an exciting time, when new medications and treatment options for complex diseases are now available to rheumatologists and their patients, but this is only possible if a patient’s insurance company approves access to these important treatments,” Dr. Shepherd notes. “For better or for worse, healthcare in the U.S. depends on a third-party payer system; however, this system is not necessarily designed for patients and providers, and that’s where the ISC comes in.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

As an interface between rheumatology practices and insurance companies, the ISC plays an important role in following changes in insurance policies and advocating for rheumatology practice perspectives—and often, it’s practices that bring insurance concerns to light. For example, practices routinely contact the ISC when a payer tries to force stable patients to switch treatments or require practices to obtain medications through a specialty pharmacy. The ISC continues to work closely with ACR staff and other organizations to share such concerns, which has led to successful changes with this issue and many other payer policies.

“We are here to support the relationship between payers and practices and make it work for our members, to help them provide the best care available for their patients,” Dr. Shepherd says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Driven to Advance Patient Care

Dr. Shepherd brings a perspective to rheumatology care and practice advocacy that is both global and local. Born in Scotland, she moved to Texas and grew up shuttling back and forth between Scotland and Texas before attending medical school at Vanderbilt University School of Medicine in Nashville, Tenn. Here, she chose rheumatology as a third-year medical student after seeing a young patient in emergency care for multi-system organ disease that had not been diagnosed. “This young man was very ill, and it was amazing to see how the rheumatology team swooped in, diagnosed lupus and quickly helped him regain health,” she explains. “Seeing this inspired me to pursue my own rheumatology practice.”

After completing her internal medicine residency and rheumatology fellowship at Washington University in St. Louis, she landed her first job in rheumatology care at Lancaster General Health, Pa., where she has built her career. Currently she is chief of rheumatology and director of the hospital’s Osteoporosis Service Line.

Page: 1 2 | Single Page
Share: 

Filed under:InsuranceLegislation & AdvocacyProfiles Tagged with:ACR Insurance Subcommittee (ISC)AdvocacyCommittee on Rheumatologic Care (CORC)insurance advocacyRebecca Shepherd

Related Articles

    New Wins, Ongoing Challenges for ACR Insurance Subcommittee

    July 3, 2019

    Corrections to reimbursement system errors with Aetna and a Medicare contractor demonstrate the latest wins for all providers by the ACR’s Insurance Subcommittee. But the committee remains hard at work advocating for rheumatologists on several fronts.

    Protect Your Practice: Action Update From the ACR’s Insurance Subcommittee

    November 5, 2018

    Both private and academic rheumatology practices face payer challenges that put the health of their patients and their practices at risk. To make sure the rheumatologist perspective is heard by payers, “the ACR’s Insurance Subcommittee (ISC) serves as the interface between payers and our members and ACR colleagues,” explains Sean Fahey, MD, a rheumatologist in…

    Practice Page: The ACR’s Insurance Subcommittee Facilitates Better Communication With Health Insurers for Rheumatology Practices

    June 1, 2013

    Committee is working to develop policy and programs to help ACR members deal with the administrative requirements of health insurance plans

    ACR Insurance Subcommittee Tackles Known Issues

    April 10, 2023

    During a busy start to 2023, the ISC has been advocating with payers to address multiple coverage and reimbursement challenges facing rheumatology practices, including Cigna’s modifier 25 requirements, hydroxychloroquine access and coverage for apremilast combination therapy.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences